Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson’s Disease

Cited by papers we hold 4

• Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies · 2023
  No notice
• Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease · 2022
  No notice
• Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease · 2021
  No notice
• Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.